FTC Clears Antitrust Review for ON Semiconductor's Acquisition of Synaptics (NASDAQ: ON)

ON Semiconductor Corporation (NASDAQ: ON) cleared a critical regulatory milestone in its planned acquisition of Synaptics Incorporated on August 12, 2026, when the Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The FTC's decision removes the HSR antitrust review requirement ahead of schedule, advancing the deal toward its anticipated mid-2027 close. Shares of ON fell -2.11% on Thursday, August 13, while the S&P 500 gained 0.70%.

Deal Terms and Regulatory Progress

• Merger structure: onsemi's wholly owned subsidiary, Sonic Acquisition Corp., will merge with and into Synaptics, leaving Synaptics as a wholly owned subsidiary of onsemi upon closing.
• Agreement date: The Agreement and Plan of Reorganization was signed on June 25, 2026.
• HSR filing date: Both parties submitted their HSR notifications on July 17, 2026, just 26 days before the FTC granted early termination.
• Remaining conditions: Closing still requires approval from Synaptics stockholders and certain other regulatory approvals or clearances not specified in the filing.
• Expected close: Both parties continue to target mid-2027, subject to satisfaction or waiver of remaining closing conditions.

Why It Matters

Early termination of the HSR waiting period is a meaningful procedural win. The FTC typically allows a 30-day review window, and early termination indicates no immediate antitrust objection to the combination. For a semiconductor transaction of this scale, clearing U.S. antitrust review ahead of schedule reduces one of the more uncertain regulatory risks that typically accompany deals in the chip sector.

The acquisition would bring Synaptics, a maker of human interface and IoT chips, under the onsemi umbrella. onsemi has a market capitalization of $31.8B, and the combination, once completed, would expand its addressable market in connectivity and edge AI processing applications. However, shareholder approval from Synaptics investors and additional regulatory clearances remain outstanding before the transaction can close.

Wall Street View

Analyst sentiment on ON heading into the regulatory development leaned constructive, with the most recent consensus from August 1, 2026 showing 13 Buy ratings and 20 Hold ratings among covering analysts, alongside 5 Strong Buy calls and no Sell ratings. No specific price target changes tied to the FTC development were available in the source data at the time of publication.

Investor Takeaway

The FTC's early termination clears the most immediate U.S. regulatory hurdle, but the deal's path to mid-2027 still depends on Synaptics stockholder approval and other regulatory sign-offs that have not yet been obtained. For ON shareholders, the key forward variable is whether the remaining approvals proceed on schedule: any delay beyond mid-2027 could introduce integration uncertainty into onsemi's near-term operational planning. The transaction's full financial impact on ON's balance sheet, including how the deal will be funded, has not been disclosed in publicly available materials.